Skip to main content
ConductScienceScienceDex
NIH funding notice PAR-22-262

Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)

Closed on January 7, 2024.

Posted
January 31, 2023
Close date
January 7, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $74,999 in first-year total cost, median $74,999.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IIDB-X (02)]1

Most frequent institutions

  1. FRED HUTCHINSON CANCER CENTER1
Competing awards under PAR-22-262 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference2R13OD024033-08KUBLIN, JAMES G.ROXBY, ALISON CHRISTINAFRED HUTCHINSON CANCER CENTER, WA$74,999ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
PAR-22-262: Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) | ScienceDex | ConductScience